A Phase 2 Trial of Lutikizumab, an Anti-Interleukin 1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

Wiley

Online

2019-01-18

DOI

10.1002/art.40840

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now